Pulmonary Medicine / 2012 / Article / Tab 3

Clinical Study

Persistent Pulmonary Hypertension of Non Cardiac Cause in a Neonatal Intensive Care Unit

Table 3

Treatment ( ).

Inhaled nitric oxide, (%)19 (24.3%)
Surfactant, (%)24 (30.7%)
Dopamine, (%)57 (73%)
Dobutamine, (%)35 (44.8%)
Epinephrine, (%)3 (3.8%)
Sildenafil, (%)12 (15.3%)
Diuretics, (%)33 (42.3%)
Sedation, (%)71 (91%)
Oxygen, (%)78 (100%)
Days of oxygen, median (min–max)6 (1–114)
Mechanical ventilation, (%)71 (91%)
Days of mechanical ventilation, median (min–max)7 (1–114)
Extracorporeal membrane1 (1.2%)
oxygenation (ECMO), (%)
Days of ECMO17

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.